Supernus Pharmaceuticals Inc (SUPN)
Debt-to-assets ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | 379,252 | 361,751 |
| Total assets | US$ in thousands | 1,368,070 | 1,277,670 | 1,702,510 | 1,689,150 | 1,504,100 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.22 | 0.24 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $1,368,070K
= 0.00
Supernus Pharmaceuticals Inc's debt-to-assets ratio has shown a decreasing trend over the years, from 0.24 in December 2020 to 0.22 in December 2021, and subsequently decreasing to 0.00 in December 2022, 2023, and 2024. A lower debt-to-assets ratio indicates that the company relies less on debt to finance its assets, which can be viewed positively by investors and lenders as it signifies lower financial risk. The decrease in the ratio to 0.00 in the later years may suggest that the company has significantly reduced its debt relative to its asset base, potentially improving its financial stability and leverage position.
Peer comparison
Dec 31, 2024